The One Health Trust, funded by the World Health Organization and the British Academy, hosted a two-day workshop focused on developing inclusive policy recommendations for our changing world. The workshop highlighted the urgent need to address antimicrobial resistance (AMR), which occurs when germs (including bacteria, viruses, fungi, and parasites) adapt to resist treatment, leading to […]
Venus Remedies, one of India’s leading exporters of generic medicines in critical care segments, has further expanded the reach of its oncology drugs in the Asia Commonwealth of Independent States (CIS) region with marketing authorisations from Ukraine for three cancer drugs, including paclitaxel, oxaliplatin and irinotecan.With revenues projected to grow from US $607 million in […]
Solera Health, the premier technology platform for connecting people seamlessly and easily to health solutions that work, today announced a collaboration with Aon (NYSE: AON), a leading global professional services firm. This joint effort helps more employers deliver personalized employee health experiences and optimize health outcomes for the most common chronic conditions. By integrating the […]
Venus Remedies, a globally recognised pharmaceutical company, has been awarded the Good Manufacturing Practices (GMP) certification for its facilities from the Ministry of Health, Libya. This accomplishment is a testament to the company’s commitment to quality, safety and efficiency in the production of injectable pharmaceuticals, including oncology, antibiotic and anticoagulant medications. Mr. Saransh Chaudhary, CEO […]
Venus Remedies, a globally recognised pharmaceutical company, has been awarded the Good Manufacturing Practices (GMP) certification for its facilities from the Ministry of Health, Libya. This accomplishment is a testament to the company’s commitment to quality, safety and efficiency in the production of injectable pharmaceuticals, including oncology, antibiotic and anticoagulant medications. Mr. Saransh Chaudhary, CEO […]
A. Menarini India Private Limited (‘Menarini India’), a leading Italian pharmaceutical company strengthens its presence in dermatology, and has solidified its strategic position by entering into an exclusive partnership with esteemed French pharmaceutical giant – Pierre Fabre Laboratories. Pierre Fabre Laboratories stands as a global leader in dermo-cosmetics, renowned for its French expertise and research-backed […]
Shanghai Henlius Biotech, Inc. (2696.HK) has entered into an exclusive license agreement with Intas Pharmaceuticals Limited (“Intas”) for the development and commercialisation in Europe and India for several indications including ES-SCLC, and specific formulation of HANSIZHUANG (serplulimab injection), Henlius’ novel anti-PD-1 mAb. In June 2018, Henlius and Accord Healthcare Ltd., a subsidiary of Intas, entered into a license agreement, under […]
GC Aesthetics®, a long-established brand in breast aesthetics, and Bimini Health Tech (“Bimini”), a pioneer in novel healthcare solutions, are pleased to announce their groundbreaking Joint Venture partnership aimed at revolutionizing breast reconstruction worldwide. This strategic collaboration combines GC Aesthetics’ 40 years of experience in design, manufacturing, and distribution of silicone breast Implants with Bimini’s expertise […]
Optimize Health, one of the nation’s most trusted remote care platforms, is thrilled to announce its strategic partnership with the Florida Association of Accountable Care Organizations (FLAACOs). This collaborative effort marks a significant advancement in value-based care via remote patient monitoring and showcases how remote chronic disease management enhances patient engagement, improves outcomes, and can […]
Adiso Therapeutics, Inc., a clinical-stage biotechnology company committed to creating medicines that treat inflammatory diseases and improve the lives of patients and their families, today announced positive topline data from its Phase 1b multiple ascending dose (MAD) clinical trial evaluating ADS051 (BT051) in patients with moderate-to-severe ulcerative colitis (UC). The data were presented today at the […]
